Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIVATE-Kids: Mitapivat in Pediatric Pyruvate Kinase Deficiency
NCT05175105Phase 3Active, not recruiting
- Sponsor
- Agios Pharmaceuticals
- Start
- Jun 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of mitapivat in pyruvate kinase deficiency (PKD), sponsored by Agios Pharmaceuticals. Started Jun 2022; status: active, not recruiting.
02
Drugs
mitapivat
03
Conditions
pyruvate kinase deficiency (PKD)
Beyond the preview
Go deeper on NCT05175105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05175105.